News

Drug Development Is Slowing Down After Cuts at the FDA
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
Infectious Disease Advisor20h
FDA Drug Approval Decisions Expected in May 2025
Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.
FDA to phase out some animal testing requirements, possibly replace them with AI models
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
Cancer Therapy Advisor5d
FDA Roundup: Oncology Drug Approvals in 2025
On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...
To promote drug safety, FDA to replace animal testing with AI-based experiments, other methods
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
US FDA to phase out animal testing in drug development
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
CNN8d
FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs
To get FDA approval, scientists must be able to demonstrate that a new drug or treatment is safe and effective. And currently, before they can test a new therapy in humans, they must show proof ...